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 2 
ABSTRACT 21 
 22 
Wild blueberries are a rich source of polyphenols and other compounds that are highly 23 
metabolized by the intestinal microbiota and may at the same time affect the intestinal 24 
environment itself.  25 
A repeated-measures, crossover dietary intervention on human volunteers was designed 26 
to study the effect of six week consumption of a wild blueberry (Vaccinium 27 
angustifolium) drink, versus a placebo drink, in modulating the intestinal microbiota. 28 
Relative to total eubacteria, Bifidobacterium spp. significantly increased, following 29 
blueberry treatment (P<0.05) while Lactobacillus acidophilus, increased after both 30 
treatments (P<0.05). No significant differences were observed for Bacteroides spp., 31 
Prevotella spp., Enterococcus spp. and Clostridium coccoides. 32 
Bifidobacteria, which have been largely proposed of benefit for the host, appeared to be 33 
selectively favored suggesting an important role of polyphenols and fiber present in wild 34 
blueberries. Results obtained suggest that regular consumption of a wild blueberry drink 35 
can positively modulate the composition of the intestinal microbiota.  36 
 37 
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INTRODUCTION 41 
Compared to other cultivated species of blueberries, wild blueberry (Vaccinum 42 
augustifolium) is characterized by a higher anthocyanin content, as well as significant 43 
levels of total fiber, sitosterol, manganese, vitamin B6, vitamin C and vitamin K (1).  44 
The high antioxidant power of wild blueberries may in part explain their protective 45 
activity against degenerative processes connected to oxidative stress and the presence of 46 
reactive oxygen species, which is also the main reason for the cardiovascular protective 47 
and anticarcinogenic activity attributed to phenolic-containing foods in general (2). 48 
In addition, an increasing interest in the relationship between intestinal microorganisms 49 
and overall health of the human host has been developing in recent years. It is well 50 
known that intestinal microbiota is a key factor contributing to digestive processes, 51 
producing vitamins, transforming bile acids and generating a multitude of bioactive 52 
compounds from food components. For example short-chain fatty acids are derived from 53 
the fermentation of fiber, conjugated linoleic acids from linoleic acid, enterodiol and 54 
enterolactone from lignans and equol from daidzein, all of which have been linked to 55 
anti-cancer, anti-inflammatory and other health-promoting effects (3,4). Beneficial 56 
intestinal microbiota also play an important role on immunity through the modulation of 57 
local and systemic immune response and can prevent the growth of pathogenic bacteria 58 
by mechanisms of competition known as ‘barrier effect’ (5).  59 
Although the composition of intestinal microbiota species and sub-species is extremely 60 
variable from person to person, it is relatively constant for every single adult, and it is 61 
mostly determined by genetic factors and by intestinal colonization in the early stages of 62 
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life (6). However, its composition can be significantly influenced by several 63 
environmental factors, such as antibiotic usage and diet (7). 64 
Diet can positively modulate intestinal microbiota through consumption of probiotics or 65 
prebiotics. Oligosaccharides, such as inulin, lactulose, and dietary fiber in general, have 66 
shown a strong prebiotic activity, mostly promoting the selection of lactobacilli and 67 
bifidobacteria (8). A recent review focused on interactions between phenolic compounds 68 
present in foods and intestinal microbiota emphasizing how this two-way interaction 69 
affects both the production and bioavailability of bioactive compounds and the selection 70 
and/or repression of specific microbial populations (9). Only few studies have shown a 71 
significant effect of polyphenols (e.g. those from tea or soy isoflavones) in modulating 72 
intestinal microbiota, although the mechanisms have not been delineated (10,11). 73 
Since wild blueberries are a good source of polyphenols (in particular anthocyanins, but 74 
also other flavonoids and phenolic acids) and dietary fiber, it is likely that they exert a 75 
prebiotic activity and modulate the gut microbiota. Such activities have been previously 76 
documented in vitro and in vivo on animal models: in particular, blueberry extracts have 77 
been shown to increase the population size of lactobacilli and bifidobacteria in human 78 
feces and after administration to rats (12). 79 
To our knowledge, however, the prebiotic activity of wild blueberries and their ability to 80 
influence human intestinal microbiota has never been evaluated in humans. Thus we 81 
studied the potential prebiotic activity of wild blueberries and their ability to modulate 82 
intestinal microbiota on a subgroup of volunteers enrolled in a larger project that 83 
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investigated the effects of wild blueberry (Vaccinium angustifolium) intake on endothelial 84 
function, oxidative stress and inflammation.  85 
 86 
EXPERIMENTAL METHODS 87 
Experimental design  88 
A repeated-measures, crossover dietary intervention was designed. A total of twenty 89 
healthy male individuals, ages 45.9 ± 8.6 years and BMI 25.1 ± 2.8 kg/m2 were recruited. 90 
Volunteers were selected on the basis of a medical history questionnaire and an interview 91 
to evaluate their dietary habits and ensure that they were as homogeneous as possible, in 92 
particular for fruit and vegetable consumption. This was obtained by means of a food 93 
frequency questionnaire previously published and specifically revised to focus on food 94 
sources rich in antioxidants (13). Exclusion criteria were: high (> 5 portions/day) or low 95 
(<2 portions/day) intake of fruits and vegetables; regular use of medications or dietary 96 
supplements; habitual alcohol consumption (< 3 drinks per week); adherence to specific 97 
vegetarian diets (e.g. vegan or macrobiotic); recent use (less than 1 month) of antibiotics 98 
or medications affecting gastrointestinal function; intake of specific prebiotics or 99 
probiotics and history of chronic constipation, diarrhea or any other gastrointestinal 100 
problem. 101 
Participants were randomly divided in two groups. Subjects in the first group received a 102 
wild blueberry drink (25 g wild blueberry powder in 250 ml water) every day for 6 103 
weeks, in addition to their habitual diet. After a 6 week wash-out period, they received a 104 
daily placebo drink (250 ml water, 7.5 g fructose, 7 g glucose, 0.5 g citric acid, 0.03 g 105 
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blueberry flavour, 280 µl allura red AC 1%, 70 µl brilliant blue FCF 1%) for six weeks. 106 
Subjects in the second group followed the opposite sequence: placebo drink – wash-out – 107 
wild blueberry drink.  108 
The two drinks were freshly prepared each morning and provided to the subjects in 109 
appropriate ice boxes. Participants were instructed to keep the drinks under refrigeration 110 
and to avoid exposing it to a heat source or light and consume the drink within the 111 
morning. Every Friday, subjects received the drinks for the week-end and kept them 112 
refrigerated. 113 
For the duration of the experiment, volunteers were instructed to maintain their normal 114 
dietary and lifestyle habits (as assessed before enrollment) and to abstain from consuming 115 
anthocyanin-rich foods (a list of prohibited foods was provided).  There is generally good 116 
compliance with dietary instructions enrolling in the study subjects with similar dietary 117 
habits and asking them to maintain their normal diets. This was also ensured by a 24-hr 118 
diet recall (one day before sample collection), a 3-day food record (scheduled randomly 119 
during the two experimental periods) and a weekly direct diet interview. 120 
Wild blueberries, provided as a composite from Wayman’s (Cherryfield, ME), were 121 
freeze-dried and powdered with standard procedures (by FutureCeuticals, Momence, IL). 122 
The anthocyanin profile of the wild blueberry powder was determined by LC-DAD 123 
MS(MS) and  has been previously reported (14). One serving of wild blueberry drink 124 
provided 375 mg of anthocyanins, with peonidin-glucose (49.5 mg), malvidin-galactose 125 
(49.5 mg), delphinidin-glucose (33.8 mg) and delphinidin-galactose (29.2 mg) being the 126 
most abundant molecules. Chlorogenic acid was the main phenolic compound present 127 
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(77.5 mg) while only traces of other hydroxycinnamic acids were detected in the freeze 128 
dried wild blueberry powder.  129 
Content of sugars was determined by ultra-high-performance liquid 130 
chromatography/mass spectrometry (UPLC/MS). Glucose (Glc), fructose (Fru), 131 
saccharose (Sac) and triethylamine (TEA) were purchased from Sigma-Aldrich (St. 132 
Louis, MO, USA). Water was obtained from a MilliQ apparatus (Millipore, Milford, 133 
MA). The chromatographic system consisted of an UPLC mod. Acquity (Waters) 134 
coupled to a triple quadrupole mass spectrometer mod. Quattromicro (Waters). A 1.7 m 135 
BEH Amide column (150x2.1 mm, Waters) was used for the separation at a flow-rate of 136 
0.6 mL/min. The column was maintained at 35°C and the separation was performed in 137 
isocratic mode. The eluent was a solution of 0.2% TEA in water:0.2% TEA in CH3CN 138 
(75:25, v/v). The injection volume was 5 µl. The capillary voltage was set to 3 kV and 139 
the cone voltage was 15eV. The source temperature was 130°C, the desolvating 140 
temperature was 350°C. Data were acquired by Masslinx 4.0 software (Waters) and the 141 
analyses were performed in single ion monitoring (SIR) mode monitoring the ions with 142 
(m/z)
-
 179 and 341,  with a dwell time of 0.1 s.  143 
Each serving provided 17.1 g of sugar, of which 8.8 g fructose and 8.3 g glucose. 144 
The total fiber content of each serving was 4.5 g, of which 3.8 g insoluble fiber and 0.7 g 145 
soluble fiber, as determined by the AOAC International method 991.43 for the soluble 146 
and insoluble fiber and AACC 46.13 for the protein in the residue (15). 147 
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Participants were provided with sterile stool containers and they were asked to collect 148 
four stool samples, at the beginning and at the end of both experimental periods, which 149 
were then stored at -20°C within 12 hours for subsequent analyses. 150 
Five volunteers out of the twenty originally involved in the study did not collect fecal 151 
samples for the complete duration of the experiment and were excluded from the study. 152 
This study was conducted according to the guidelines laid down in the Declaration of 153 
Helsinki and all procedures involving human subjects were approved by the Ethics 154 
Committee of the University of Milan. Written informed consent was obtained from all 155 
subjects. 156 
 DNA extraction and quantification 157 
DNA was extracted from homogenized feces (200 mg) using the QIAamp DNA stool 158 
Mini kit (Quiagen, Hilden, Germany) following the instructions provided by the 159 
manufacturer. The final concentration of DNA was determined spectrophotometrically. 160 
A260/A280 and A260/A230 ratios were also calculated to exclude major contamination 161 
from proteins and salts. 162 
DNA samples were subsequently diluted with nuclease-free water to reach a DNA 163 
concentration of 5 ng/µl, and stored at -20°C until processing. 164 
Real-time PCR 165 
To evaluate the variation of bacterial levels from faecal samples before and after each 166 
treatment, a quantitative real-time polymerase chain reaction (PCR) protocol was 167 
performed using specific primers targeting seven different bacterial groups (Eubacteria 168 
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spp, Bacteroides spp, Bifidobacterium spp, Prevotella spp, Enterococcus spp, 169 
Lactobacillus acidophilus and Clostridium coccoides), as indicated in Table 1. 170 
The analysis was performed in duplicates, using a Fast Eva Green Supermix SYBR 171 
Green PCR Master Mix (Bio-Rad  Laboratories S.r.l., Milano, Italy) in a reaction volume 172 
of 20 µl per well (16). 173 
Quantitative PCR (qPCR) reactions were run on a CFX96 thermocycler (BioRad 174 
Laboratories).  A gradient PCR was performed initially to standardize the qPCR 175 
conditions. qPCR amplification was carried out with initial denaturation at 95°C for 3 176 
minutes, followed by 40 cycles of denaturation at 95°C for 10 seconds, annealing at 177 
55.9°C for 30 seconds, and extension at 72°C for 20 seconds. Melting curve analysis was 178 
always carried out to verify the specificity of the amplification. Data were recorded as 179 
threshold cycles (Ct), expressed as means ± standard deviation, computed using the 180 
software BioRad CFX Manager and expressed as normalized quantification (∆∆Ct) ± 181 
standard error of the mean, calculated on each bacterial group in relation to total 182 
eubacteria (17,18). 183 
The PCR analysis was performed on a subset of eight samples for each set of primers, as 184 
a screen. When significant variations or at least a definite trend were observed, the 185 
analysis was performed on the remaining samples to confirm the results and a standard 186 
curve for calculating the absolute bacterial concentrations was also measured. 187 
A standard curve for bifidobacteria was constructed by plotting the Ct values obtained for 188 
the standard cultures (different 1:2 dilutions from a mixed culture of B. longum subsp. 189 
longum DSM 20219, B. longum subsp. infantis DSM 20088, B. adolescentis DSM 20083, 190 
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B. bifidum DSM 20456, B. animalis subsp. lactis Bb12, B. breve DSM 20213; 191 
B.pseudocatenulatum DSM20438) as a linear function of the base 10 logarithm of the 192 
initial number of bifidobacteria in the culture, determined by microscope counts 193 
(Neubauer-improved counting chamber, Marienfeld GmbH).  194 
 195 
Statistical analysis 196 
Statistical analysis was performed on a personal computer with STATISTICA software 197 
(Statsoft Inc, Tulsa, OK).  Analysis of variance (ANOVA) was used to evaluate the 198 
relative variations of the different bacterial groups following wild blueberry 199 
consumption. A repeated measures ANOVA with the sequence of treatments (wild 200 
blueberry then placebo or placebo then wild blueberry) as the independent factor was 201 
performed to evaluate whether a significant carry-over effect was present. When no 202 
carry-over effect was observed, data were analyzed with ANOVA considering treatments 203 
(wild blueberry and placebo) and time (before and after treatments) as dependent factors. 204 
Differences between means were further evaluated by the least significant difference test 205 
(LSD). Results were considered significant at P<0.05.  206 
Analyses of bacterial levels were performed on stool samples from 8 subjects. The 207 
remaining available samples (n=7) were analysed in order to confirm the effect of wild 208 
blueberry drink intake on Bifidobacterium spp. and Lactobacillus acidophilus group. 209 
 210 
RESULTS AND DISCUSSION 211 
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There is paucity of research on the effect of dietary polyphenols and their metabolites on 212 
the composition on the gut microbiota while most studies have  focused on their 213 
antibacterial activity and biotransformation of polyphenols operated by the gut 214 
microbiota (9, 20). 215 
Results from this study presented on Table 2, point to the effect of wild blueberries on 216 
different gut bacterial targets. All bacterial groups studied were present in all fecal 217 
samples of the subjects tested. Statistically significant variations were observed on the 218 
sub-sample of 8 subjects for Bifidobacterium spp. (P<0.05) and Lactobacillus 219 
acidophilus group (P<0.05).  220 
To increase sample size, the PCR analysis with the same primers was performed on all 221 
available samples (n=15) and results obtained from the 8 samples were confirmed. Thus 222 
in the 15 samples, Bifidobacterium spp. increased from 1.00 ± 0.13 to 2.12 ± 0.44 (P<0.05) 223 
following the wild blueberry drink and from 1.25 ± 0.16 to 1.61 ± 0.42 following the placebo 224 
drink. Lactobacillus acidophilus group (P<0.05) increased from 0.92 ± 0.10 to 6.24 ± 1.20 225 
(P<0.05) following the wild blueberry drink and from 1.09 ± 0.14 to 6.03 ± 1.59 following 226 
the placebo drink (P<0.05). While Bifidobacterium spp. only increased after the wild 227 
blueberry drink consumption (2.12 fold  compared to eubacteria), the Lactobacillus 228 
acidophilus group increased after both treatments (6.78 and 5.53 fold following wild 229 
blueberry and placebo drink respectively). 230 
Diet can influence intestinal microbiota in both a positive and a negative way. A diet rich 231 
in protein promotes the selection of proteolytic metabolic activities whose end products, 232 
such as ammonia and N-nitroso compounds, may be toxic for the human host and may 233 
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increase colon cancer risk (21). On the other hand, microbial fermentations of fiber and 234 
carbohydrate, with the production of short chain fatty acids, is considered positive for 235 
contributing to the digestive process, enhanced absorption of minerals and 236 
immunomodulatory and cancer preventive effects (22). This is specifically associated with 237 
the activity of bacterial strains from the genera Lactobacillus and Bifidobacterium, which 238 
exert a range of health promoting effects including inhibition of procarcinogenic 239 
enzymatic activities within the microbiota, inhibition of pathogens growth, synthesis of 240 
vitamins and other beneficial bioactive compounds from food components (3,4,5). 241 
For both these bacterial groups a significant variation was observed during this dietary 242 
intervention.  243 
Our results are in agreement with previous findings in vitro and in the animal model. In a 244 
study by Molan et al., addition of a blueberry extract to mixed human fecal bacterial 245 
populations resulted in a significant increase in the number of lactobacilli and 246 
bifidobacteria (12). The same was observed in fecal samples of rats after a 6 days oral 247 
administration of the blueberry extract (12). Dietary administration of proanthocyanidin-248 
rich extracts also appear to have a similar effect. In rats whose diet was supplemented for 249 
16 weeks with a dealcoholized, proanthocyanidin-rich red wine extract, the fecal bacterial 250 
composition shifted from a predominance of  Bacteroides, Clostridium and 251 
Propionibacterium spp. to a predominance of Bacteroides, Lactobacillus and 252 
Bifidobacterium spp. (23). Furthermore, Yamakoshi et al. documented that a 253 
proanthocyanidin-rich extract from grape seeds administered for 2 weeks to healthy 254 
adults was able to significantly increase the number of bifidobacteria (24).  255 
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In our study the only bacterial group that increased significantly and exclusively after the 256 
wild blueberry treatment, is represented by the genus Bifidobacterium. Growth of 257 
bifidobacterial population may have benefited from the different components, which 258 
were contained in the wild blueberry drink, primarily fiber and anthocyanins (25,26). 259 
Evolutionarily, bifidobacteria have been subjected to a strong environmental pressure to 260 
specialize for the catabolism of a variety of nondigestible plant polymers, glycoproteins 261 
and glycoconjugates. While having relatively few proteolytic and lipolytic enzymes, they 262 
have many enzymes to hydrolyze oligosaccharides, including those characterized by less 263 
common linkages such as hemicelluloses, arabinogalactans, arabinoxylans, gums, inulins, 264 
galactomannans and branched starches (27). 265 
Since these substrates are poorly metabolized by the most common intestinal bacteria, 266 
such adaptation may be at the basis of the ability of bifidobacteria to persist in the colon 267 
when an adequate intake of dietary fiber is provided, as it was confirmed by a recent 268 
intervention study where a fiber mixture was administered to a group of fifty-nine human 269 
volunteers, increasing their bifidobacterial population (28). The β-glucosidase activity of 270 
bifidobacteria also suggests their important role in the intestinal metabolism of 271 
anthocyanins, which are present in nature mostly as glycosides (29). 272 
Additionally, the presence of anthocyanins and other polyphenols in the wild blueberry 273 
drink should be considered as a contributor in the creation of a redox environment 274 
favourable for the selection of bifidobacteria, which are benefited  by low oxidation-275 
reduction potential (30).  276 
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Moreover, the high content of vitamin K which is characteristic of wild blueberries (1) 277 
may have contributed in promoting growth of bifidobacteria. In fact, vitamin K, which 278 
cannot generally be produced by bifidobacteria, is a known growth factor for these 279 
microorganisms (31,32). 280 
We also determined the absolute bacterial concentrations for Bifidobacterium spp. 281 
(Figure 1), calculated by means of a standard curve. Although the trend is similar to the 282 
data normalized to total eubacteria, in this case the variations were not statistically 283 
significant. However, since the total number of bacteria can vary significantly from one 284 
stool sample to another, considering the absolute concentrations of the single bacterial 285 
groups can be misleading; while the proportion of each group to the total number of 286 
bacteria is more meaningful, especially if variations over time are to be considered. This 287 
choice has been already proposed and employed in other studies (33). 288 
The Lactobacillus acidophilus group includes the species most commonly employed as 289 
probiotics due to their widely recognized health promoting properties (for instance: L. 290 
acidophilus, L. gasseri, L. johnsonii, L. crispatus, L. helveticus).  291 
Interestingly, the Lactobacillus acidophilus group increased after both wild blueberry and 292 
placebo drink consumption. The only hypothesis we can formulate to explain such a 293 
result involves a determinant role of simple sugars, such as fructose or glucose, which 294 
were present in both drinks and whose non-absorbed fraction was likely fermented in the 295 
small and large intestine. In fact, lactobacilli, differently from bifidobacteria, colonize 296 
also the proximal part of the gastro-intestinal tract (34).  297 
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In addition to bifidobacteria and lactobacilli, this exploratory study also assessed other 298 
microbial groups chosen on the basis of their well- known impact on host physiology. 299 
Bacteroides spp. are the largest portion of the mammalian gastrointestinal microbiota 300 
(1010-1011 cells per gram), where they play a fundamental role in the processing of 301 
complex carbohydrates (35). Prevotella spp. and Enterococcus spp. are two of the 302 
predominant genera in human feces.  Changes in their number and enzymatic activities 303 
have been connected to specific host physiologic conditions (36, 37). Finally, the 304 
Clostridium coccoides group, also predominant in the human gut, includes species that 305 
are known butyrate-producing bacteria, thereby contributing to processes important to 306 
colonic health (38). 307 
However, no statistically significant variation or trend could be observed for any of the 308 
above microbial groups following the wild blueberry drink consumption.  309 
In conclusion, the results of this study suggest that regular consumption of a wild 310 
blueberry drink is able to favorably modulate the composition of the intestinal 311 
microbiota, increasing in particular, bacterial strains from the genus Bifidobacterium,  312 
which is considered among the most health promoting (5). 313 
Considering the discovery-based nature of this investigation, further experiments on a 314 
larger population group investigating specific species of bifidobacteria is strongly 315 
recommended. 316 
In addition, the wild blueberry drink may also be interesting as a basis for the formulation 317 
of a “functional” drink that could combine the positive prebiotic activity observed of the 318 
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wild blueberry components with the probiotic activity of live Bifidobacterium and/or 319 
Lactobacillus strains (39). 320 
 321 
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Table 1 - List of primers and their sequences used for the PCR analysis 445 
Target Primer Sequence (5’-3’) 
Annealing 
temp (°C) 
Product 
size (bp) 
Reference 
Eubacteria 
EubF1 GTGSTGCAYGGYTGTCGTCA 
50-58.5 147 
Maeda et al., 2003 
(16) 
EubR1 GAGGAAGGTGKGGAYGACGT 
Bacteroides spp. 
g-Bfra-F AYAGCCTTTCGAAAGRAAGAT 
50 495 
Matsuki et al., 2002 
(17) 
g-Bfra-R CCAGTATCAACTGCAATTTTA 
Bifidobacterium spp. 
g-Bifid-F CTCCTGGAAACGGGTGG 
55 550 
Matsuki et al., 2002 
(17) 
g-Bifid-R GGTGTTCTTCCCGATATCTACA 
Prevotella spp. 
g-Prevo-F CACRGTAAACGATGGATGCC 
55 513 
Matsuki et al., 2002 
(17) 
g-Prevo-R GGTCGGGTTGCAGACC 
Enterococcus spp. 
g-Encoc-F ATCAGAGGGGGATAACACTT 
55 337 
Matsuda et al., 2009 
(18) 
g-Encoc-R ACTCTCATCCTTGTTCTTCTC 
Lactobacillus acidophilus 
group of species* 
Forward AGAGGTAGTAACTGGCCTTTA 
58.5 391 
Malinen et al., 2003 
(19) 
Reverse GCGGAAACCTCCCAACA 
Clostridium coccoides 
g-Ccoc-F AAATGACGGTACCTGACTAA 
50 440 
Matsuki et al., 2002 
(17) 
g-Ccoc-R CTTTGAGTTTCATTCTTGCGAA 
* L. acidophilus probe detects L. acidophilus, L. amylovorus, L. amylolyticus, L. 446 
crispatus, L. gasseri and L. johnsonii. 447 
448 
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Table 2 - Relative proportion of bacterial groups compared to total eubacteria in human 449 
fecal samples (n=8). 450 
 
Wild blueberry drink                       Placebo drink   
Before   After  Before  After     
 
Lactobacillus acidophilus 
 
0.90 ± 0.12a 
 
6.18 ± 1.92b 
 
1.18 ± 0.20a  
 
6.24 ± 1.83b  
Bifidobacterium spp. 0.75 ± 0.13a 2.16 ± 0.70b 1.23 ± 0.25a 1.05 ± 0.39a 
Prevotella spp. 0.90 ± 0.08 1.28 ± 0.37 0.68 ± 0.15 0.78 ± 0.46 
Enterococcus spp. 0.83 ± 0.12 0.48 ± 0.27 0.54 ± 0.36 0.65 ± 0.17 
Bacteroides spp. 0.85 ± 0.11  1.14 ± 0.20  1.07 ± 0.16 107 ± 0.32 
Clostridium coccoides 1.19 ± 0.18 1.71 ± 0.41 1.51 ± 0.28 1.36 ± 0.20 
 451 
Values are expressed as mean ± standard error of mean (SEM) and were normalized to 1 452 
at the beginning of the study.  453 
n: number of subjects.  454 
a,b: mean values within a row with different letters were significantly different (P<0.05). 455 
  456 
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Figure 1 - Absolute concentration of bifidobacteria in human fecal samples  (n=15). 457 
  458 
Bifidobacterial cell counts versus wet fecal weight, expressed as log (cells/g) mean + 459 
SEM.  460 
BB, before blueberry; AB, after blueberry; BP, before placebo; AP, after placebo. 461 
 462 
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 469 
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